Impact of the Different Pneumococcal Serotypes on Chronic Respiratory Patients in Current Vaccination Strategies. [PDF]
Sanz Herrero F +2 more
europepmc +1 more source
Immunogenicity and safety of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults ≥18 years of age in India: A phase 3 single-arm trial. [PDF]
Giriappa B +11 more
europepmc +1 more source
Differential Impact of Pneumococcal Conjugate Vaccines on Hospitalized <i>Versus</i> Outpatient Community-Acquired Alveolar Pneumonia in Children Younger Than 5 Years Suggests Differences in Pathogenesis. [PDF]
van der Beek BA +3 more
europepmc +1 more source
Invasive Pneumococcal Disease Presenting as Austrian Syndrome in a Patient With HIV Infection: A Case Report. [PDF]
Jani S, Khaja M.
europepmc +1 more source
Pneumococcal Serotype Distribution and Coverage of Existing and Pipeline Pneumococcal Vaccines. [PDF]
King LM +13 more
europepmc +1 more source
Estimating the Health and Economic Burden of Pneumococcal Diseases Attributable to PCV21 Versus PCV20 or PPSV23 Serotypes Among Adults in Norway. [PDF]
Yi Z +4 more
europepmc +1 more source
Invasive Pneumococcal Diseases Before and After the COVID-19 Pandemic in Italy (2018-2023). [PDF]
Camilli R +9 more
europepmc +1 more source
Real world effectiveness of antipneumococcal vaccination against pneumonia in adults: a population-based cohort study, Catalonia, 2019. [PDF]
de Diego-Cabanes C +11 more
europepmc +1 more source

